TheWell Bioscience’s Post

Transfection Technologies Market Size To Hit USD 1.8 Billion by 2028 Download Free Sample Report-https://lnkd.in/dTyNZDYT The size of global transfection technologies market in terms of revenue was estimated to be worth $1.2 Billion in 2023 and is poised to reach $1.8 Billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028. Companies Working in the Market Life Technologies MaxCyte, Inc.  InvivoGen ScienCell Research Laboratories Kytopen Cell Applications, Inc.      Polysciences, Inc.  LumaCyte Middle East Molecular Biology Society - MEMBS Polyplus now part of Sartorius Marin Biologic Laboratories  Mirus Bio Avectas DeNovix Inc. PromoCell RD-BIOTECH OZ Biosciences THERAVECTYS TAAV Biomanufacturing Solutions   NanoEnTek, Inc. TOMOCUBE, INC. Cellectricon leon-nanodrugs SiSaf Ltd InVivo BioTech Services GmbH - a Bruker Company   

📢 Revolutionary Chromatography Tech Set to Transform Bioprocessing! 🌟 Solventum, a healthcare spinoff of 3M, is advancing its fibrous chromatography material, the Harvest RC Chromatographic Clarifier. 🧪 This technology enhances bioprocess efficiency by removing cells and debris in a single step, unlike traditional methods. 🚀 Masa Nakamura, a bioprocess science expert, highlights its potential for various applications, especially in cell therapy products. 🔬 Improved consistency and adaptability may transform bioprocessing in the industry. #BioprocessUpdates #Chromatography #Bioprocessing #CellTherapy #HarvestRC #Solventum #3MInnovation #Biotech #HealthcareTechnology #Efficiency #ResearchAndDevelopment #ScientificBreakthrough #MaterialScience #Clarification #BioprocessEfficiency #InnovationInHealthcare ▷ Read the full article here: 📎 https://lnkd.in/d-CkrMqx

🚀 Exciting Advances in Peptide Synthesis! 🧬 A recent study published in Nature Communications unveils an innovative electrochemical method for synthesizing peptide aldehydes. This approach uses mild, biocompatible conditions to efficiently break C–N bonds in cyclic amines, enabling the creation of unnatural peptide structures. This breakthrough could greatly enhance the design of peptide-based drugs, thanks to its precise control and potential for large-scale applications! 🌟 🔗 #PeptideSynthesis #Electrochemistry #DrugDiscovery #Biotech #Innovation https://lnkd.in/gpuYWuZY

Molecular Biology Enzymes Market Revenue to be Worth $29.7 billion by 2026 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 https://lnkd.in/g_fDhbp3 The global molecular biology enzymes market in terms of revenue was estimated to be worth $15.3 billion in 2021 and is poised to reach $29.7 billion by 2026, growing at a CAGR of 14.2% from 2021 to 2026. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Thermo Fisher Scientific Merck Group Promega Corporation New England Biolabs Illumina Takara Bio Inc. QIAGEN Agilent Technologies Roche Bio Basic Inc. Jena Bioscience GmbH Molecular Biology Resources, Inc. Bio-Rad Laboratories Zymo Research Corp Integrated DNA Technologies LGC Biosearch Technologies NZYtech Lucigen Corp. MOBITEC Genekam Biotechnology AG Aldevron Randox Laboratories Limited (Mumbai) ADS BIOTEC INC Hangzhou Matridx Biotechnology Goldsite Diagnostics Inc. #MolecularBiologyEnzymes #MolecularBiologyEnzymesMarket

Cell Culture Market | Growing at CAGR 13.4% 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 👉https://lnkd.in/dKYiAmdh The global cell culture market in terms of revenue was estimated to be worth $30.9 billion in 2024 and is poised to reach $57.9 billion by 2029, growing at a CAGR of 13.4% from 2024 to 2029. Companies From the Market USA Scientific LABCLINICS, S.A Qureator Lifeline Cell Technology Unicorn Biotechnologies      OmniBRx Biotechnologies Pvt Ltd     Qkine PHILOS Membrane PL BioScience GmbH BioHarvest Sciences   Boston Institute of Biotechnology, LLC      Tanvex CDMO Saksham Technologies Pvt. Ltd. - Suppliers Of Laboratory, Medical, Analytical & Process Equipments      Aber Instruments Ltd Florabio A.Ş.      Biostream International Peky Biotech      AMSBIO  Ovizio Green Bioactives      Pharmatest Services    SYNENTEC    Polyclone Bioservices    Stemgent AIM Biotech   DC Fine Chemicals     Phase Holographic Imaging Prince Sterilization Services microLIQUID       Saguaro Biosciences Quantis Biotechnology AXT PTY LTD  BioXpedia A/S Cellexus Solentim BioNordika Denmark A/S Finesse Solutions    RADOBIO SCIENTIFIC CO.,LTD    ImmuONE     Proliant Health & Biologicals

Biomaterials Market Size To Hit USD 64.2 billion by 2029 Download Free Sample Report-https://lnkd.in/dV-DQEht The global biomaterials market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029. Companies Working in the Market Nordson Polymer Processing Systems  Erthos Agdia Inc    Geistlich Pharma North America, Inc.      Luxfer MEL Technologies Solesis Rheolution  Polybion Tepha, Inc. Himed GoZen CelluForce  UNCAGED Innovations AEQUOR, Inc.     From Fauna  HomeLab™ at UC San Diego      3-D Matrix North America Axent Biosciences    Avioq Kano Therapeutics  EcoSynthetix Inc. Xylyx Bio, Inc. curasan AG PolyAnalytik Inc.  PPD Meditech Clemson University Department of Bioengineering The Fischell Department of Bioengineering, University of Maryland  Advanced Biologics Centre for Ocular Research & Education (CORE)   Brown University Institute for Biology, Engineering, and Medicine  Ligandal AmacaThera FzioMed, Inc. Spiderwort Inc. Eminent Spine Volumetric Biomomentum Inc. Noblegen Inc

Optimize your microfluidic drug testing platforms with our specialized primary cells. Gain deeper insights into cellular responses with a focus on precise functionality. Call +91-965-4321-400 to get a quotation for primary and stem cells for your research. #primarycells #cellculture #drugtesting #research #microfluidics #drugdiscovery #biotech #science #BIORESEARCH

Organ-On-Chip Market Size to Reach $631,073 thousand by 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭  https://lnkd.in/dzKR9VCV The size of global organ-on-chip market in terms of revenue was estimated to be worth $23,285 thousand in 2024 and is poised to reach $631,073 thousand by 2029, growing at a CAGR of 38.6% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Emulate, Inc. (US), MIMETAS B.V. (Netherlands), TissUse GmBH (Germany), Netri SAS (France), Insphero (Switzerland), Axosim (US), Obatala Sciences (US), SynVivo, Inc. (US), Nortis, Inc. (US) 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲: Micronit Microtechnologies B.V. HUREL AlveoliX Organovo Holdings, Inc. Ascendance Biotechnology, Inc. Biogen BioIVT SynVivo, Inc IVTech QurAlis Elveflow Microfluidics | an Elvesys brand InSphero AG Emulate, Inc. MIMETAS Hesperos Inc. TissUse GmbH Nortis Farmaceutica HUREL CN BIO INNOVATIONS LIMITED AxoSim Technologies Kirkstall Ltd Cherry Biotech SynVivo, Inc Vitrocell Systems GmbH Organovo Holdings, Inc. IVTech Srl uFluidix Elveflow Microfluidics | an Elvesys brand Bronkhorst imec the Netherlands Penn Medicine, University of Pennsylvania Health System Beonchip Molecular Devices

The global 𝐁𝐢𝐨𝐩𝐫𝐞𝐬𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 market in terms of revenue was estimated to be worth $4.4 billion in 2024 and is poised to reach $7.1 billion by 2029, growing at a CAGR of 9.8% from 2024 to 2029. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐚𝐭 https://lnkd.in/gtHn_32S Recent Developments of Biopreservation Industry: - In 2024, Merck invested more than USD 321.7 million (EUR 300 million) into a new Bioprocessing Production Center in Daejeon, South Korea. The new site is the largest investment by Merck’s Life Science business sector in the Asia Pacific to date and demonstrates the company’s commitment to expanding its capacities in the fast-growing region. Merck expects the investment to create approximately 300 additional jobs by the end of 2028. - In 2024, Thermo Fisher Scientific introduced its newest line of high-performance, ultra-low temperature (ULT) freezers. With enhancements to performance, user experience, and energy efficiency, the Thermo Scientific TSX Universal Series ULT Freezers seamlessly adapt to scientists’ workflows across a variety of lab settings, marking a new era in performance, reliability, and sustainability. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Thermo Fisher Scientific Merck PHC Holdings Corporation Azenta Life Sciences Azenta Life Sciences(APAC) Avantor Sartorius ThermoGenesis Holdings, Inc. Bio-Techne BioLife Solutions, Inc. Cell&Co BioServices - Cryoport group So-Low Environmental Equipment Shanghai Genext Medical Technology Co., Ltd Helmer Scientific Arctiko NIPPON Genetics EUROPE STEMCELL Technologies STEMCELL Technologies China AMSBIO OPS Diagnostics ASKION OEM-Services Dohmeyer X-Therma Inc. IC Biomedical, LLC Taiyo Nippon Sanso India Pvt. Ltd. Froilabo - Firlabo SAS Cellbiosis Healthcare & Lifesciences #Biopreservation #Biopreservationmarket

Organ-On-Chip Market worth $631,073 thousand by 2029 Download PDF Brochure: https://lnkd.in/dEdqgnYK The size of global organ-on-chip market in terms of revenue was estimated to be worth $23,285 thousand in 2024 and is poised to reach $631,073 thousand by 2029, growing at a CAGR of 38.6% from 2024 to 2029. Top companies working in market MIMETAS - The Organ on a Chip Company TissUse GmbH NETRI Emulate, Inc. CN BIO INNOVATIONS LIMITED InSphero SynVivo, Inc. AxoSim, Dynamic42 GmbH React4life Obatala Sciences AlveoliX Beonchip INITIO CELL NETRI Hesperos Inc., Lena Biosciences Revivocell Ltd. Altis Biosystems BiomimX® Srl Cherry Biotech Fluigent Elveflow Microfluidics | an Elvesys brand #OrganOnChip #Bioengineering #LabOnAChip #BiomedicalResearch #TissueEngineering #Microfluidics #DrugDevelopment #InVitroModels #PharmaResearch #Biotechnology